5-BROMOPENTYL ACETATE | CAS:15848-22-3

We serve 5-BROMOPENTYL ACETATE CAS:15848-22-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-BROMOPENTYL ACETATE

Chemical Name:5-BROMOPENTYL ACETATE
CAS.NO:15848-22-3
Synonyms:5-BROMOPENTYL ACETATE
5-Bromoamyl acetate
5-bromo-1-pentanyl acetate
1-Pentanol, 5-bromo-, acetate
Acetic Acid 5-Bromopentyl Ester
5-Bromo-n-amyl acetate
Molecular Formula:C7H13BrO2
Molecular Weight:209.08100
 
Physical and Chemical Properties:
Density:1.255
Boiling point:109-110ºC
Flash point:>230°F
Index of Refraction:1.462
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 5-BROMOPENTYL ACETATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-n-amyl acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Bromo-n-amyl acetate Use and application,5-bromo-1-pentanyl acetate technical grade,usp/ep/jp grade.


Related News: With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate manufacturer With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.2,6-Difluorobenzyl bromide supplier The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.2-Aminobenzotrifluoride vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.